Pharmacotherapy of schizophrenia: toward a metabolomic-based approach

What is it about?

This review focuses on the most common metabolomic fingerprints of the different pathways involved in the pathophysiology of schizophrenia, and the potential development of novel metabolomic-related pharmacotherapies for improved treatment of schizophrenia

Featured Image